Letter: persistence of anti-infliximab antibodies after discontinuation of infliximab in patients with IBD

C Steenholdt; J Brynskov; K Bendtzen

doi:10.1111/j.1365-2036.2012.05204.x

Letter: persistence of anti-infliximab antibodies after discontinuation of infliximab in patients with IBD

Mave-, Tarm- og Leversygdomme

11 Citationer (Scopus)

Originalsprog	Engelsk
Tidsskrift	Alimentary Pharmacology and Therapeutics
Vol/bind	36
Udgave nummer	5
Sider (fra-til)	499-500; author reply 501
ISSN	0269-2813
DOI	https://doi.org/10.1111/j.1365-2036.2012.05204.x
Status	Udgivet - 2012

Adgang til dokumentet

10.1111/j.1365-2036.2012.05204.x

Citationsformater

@article{3ebae26fb09a4f0e96737b741ac537c2,

title = "Letter: persistence of anti-infliximab antibodies after discontinuation of infliximab in patients with IBD",

keywords = "Anti-Inflammatory Agents, Antibodies, Monoclonal, Antibodies, Monoclonal, Humanized, Autoantibodies, Female, Humans, Inflammatory Bowel Diseases, Male, Tumor Necrosis Factor-alpha",

author = "C Steenholdt and J Brynskov and K Bendtzen",

year = "2012",

doi = "10.1111/j.1365-2036.2012.05204.x",

language = "English",

volume = "36",

pages = "499--500; author reply 501",

journal = "Alimentary Pharmacology and Therapeutics",

issn = "0269-2813",

publisher = "John Wiley and Sons Inc.",

number = "5",

}

TY - JOUR

T1 - Letter

T2 - persistence of anti-infliximab antibodies after discontinuation of infliximab in patients with IBD

AU - Steenholdt, C

AU - Brynskov, J

AU - Bendtzen, K

PY - 2012

Y1 - 2012

KW - Anti-Inflammatory Agents

KW - Antibodies, Monoclonal

KW - Antibodies, Monoclonal, Humanized

KW - Autoantibodies

KW - Female

KW - Humans

KW - Inflammatory Bowel Diseases

KW - Male

KW - Tumor Necrosis Factor-alpha

U2 - 10.1111/j.1365-2036.2012.05204.x

DO - 10.1111/j.1365-2036.2012.05204.x

M3 - Journal article

C2 - 22860616

SN - 0269-2813

VL - 36

SP - 499-500; author reply 501

JO - Alimentary Pharmacology and Therapeutics

JF - Alimentary Pharmacology and Therapeutics

IS - 5

ER -